Chapter 26 : Immunogenetics of the Host Response to Bacteria and Parasites in Humans

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Immunogenetics of the Host Response to Bacteria and Parasites in Humans, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817978/9781555812140_Chap26-1.gif /docserver/preview/fulltext/10.1128/9781555817978/9781555812140_Chap26-2.gif


The role of genetic factors in common infectious diseases can be investigated by the analysis of several complementary traits. These traits include clinical phenotypes, which are generally binary (i.e., affected or unaffected); biological phenotypes, such as measures of infection, which may be quantitative (e.g., fecal egg counts in schistosomiasis) or binary (seropositive/seronegative); and measures of the immune response. Sections in this chapter focus on the main findings obtained in studies of susceptibility or resistance to mycobacterial and certain parasitic infections. Tuberculosis and leprosy, the most common human mycobacterial diseases, are caused by and , respectively. Many studies of familial aggregation, twin studies, and segregation analyses have clearly shown that leprosy susceptibility has a significant genetic component. Association studies between leprosy and HLA have provided other lines of evidence for the role of genetic factors in diseases caused by . In tuberculoid leprosy, the most consistent results were obtained for HLA-DR2. Segregation analyses on malaria infection levels have been performed in populations from Cameroon and Burkina Faso. Infection levels were assessed by multiple measurements of parasitemia, and the data were adjusted for factors known to influence parasitemia, such as season, area of residence, and age of the subject.

Citation: Abel L, Casanova J. 2002. Immunogenetics of the Host Response to Bacteria and Parasites in Humans, p 395-406. In Kaufmann S, Sher A, Ahmed R (ed), Immunology of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817978.ch26
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Summary of the methods and strategies used to identify the genes and genetic polymorphisms involved in human infectious diseases. The genetic etiology of rare Mendelian disorders can be determined by several strategies. Linkage analysis is usually the first step in the positional cloning approach, although the identification of visible cytogenetic rearrangements can be of great help in the mapping of the gene. Another strategy, known as the candidate gene approach (“by hypothesis”), involves the prior selection of genes (from animal models or in vitro experiments), which are then tested by functional arrays and/or mutation detection. Another promising strategy, which may be more fruitful in the future, is based on analysis of the differential expressions of genes in tissues from affected and healthy individuals. In common infectious diseases, linkage studies (model based or model free) are used to search for a chromosomal region that segregates nonrandomly with the infectious disease-related phenotype within families. The role of polymorphisms of candidate genes located within this candidate region is tested by population-based or family-based association studies. Candidate genes by hypothesis can also be chosen on the basis of their function or homology to animal loci. Evidence for an association should be validated by functional studies to determine whether the detected polymorphism modifies gene expression or the gene product in a manner that may affect susceptibility to the disease.

Citation: Abel L, Casanova J. 2002. Immunogenetics of the Host Response to Bacteria and Parasites in Humans, p 395-406. In Kaufmann S, Sher A, Ahmed R (ed), Immunology of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817978.ch26
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Abel, L.,, M. Cot,, L. Mulder,, P. Carnevale,, and J. Feingold. 1992. Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am. J. Hum. Genet. 50: 1308 1317.
2. Abel, L.,, and F. Demenais. 1988. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade Island. Am. J. Hum. Genet. 42: 256 266.
3. Abel, L.,, F. Demenais,, A. Prata,, A. E. Souza,, and A. Dessein. 1991. Evidence for the segregation of a major gene in human susceptibility / resistance to infection by Schistosoma mansoni. Am. J. Hum. Genet. 48: 959 970.
4. Abel, L.,, and A. J. Dessein. 1997. The impact of host genetics on susceptibility to human infectious diseases. Curr. Opin. Immunol. 9: 509 516.
5. Abel, L.,, and A. J. Dessein. 1998. Genetic epidemiology of infectious diseases in humans: design of population-based studies. Emerg. Infect. Dis. 4: 593 603.
6. Abel, L.,, V. D. Lap,, J. Oberti,, N. V. Thuc,, V. V. Cua,, M. Guilloud- Bataille,, E. Schurr,, and P. H. Lagrange. 1995. Complex segregation analysis of leprosy in southern Vietnam. Genet. Epidemiol. 12: 63 82.
7. Abel, L.,, and B. Muller-Myhsok. 1998. Maximum-likelihood expression of the transmission / disequilibrium test and power considerations. Am. J. Hum. Genet. 63: 664 667.
8. Abel, L.,, F. O. Sanchez,, J. Oberti,, N. V. Thuc,, L. V. Hoa,, V. D. Lap,, E. Skamene,, P. H. Lagrange,, and E. Schurr. 1998. Susceptibility to leprosy is linked to the human NRAMP1 gene. J. Infect. Dis. 177: 133 145.
9. Alcais, A.,, F. O. Sanchez,, N. V. Thuc,, V. D. Lap,, J. Oberti,, P. H. Lagrange,, E. Schurr,, and L. Abel. 2000. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships. J. Infect. Dis. 181: 302 308.
10. Allen, S. J.,, A. O’Donnell,, N. D. Alexander,, M. P. Alpers,, T. E. A. Peto,, J. B. Clegg,, and D. J. Weatherall. 1997. Alpha_- Thalassemia protects children against disease caused by other infections as well as malaria. Proc. Natl. Acad. Sci. USA 94: 14736 14741.
11. Altare, F.,, A. Durandy,, D. Lammas,, J. F. Emile,, S. Lamhamedi,, F. Le Deist,, P. Drysdale,, E. Jouanguy,, R. Doffinger,, F. Bernaudin,, O. Jeppsson,, J. A. Gollob,, E. Meinl,, A. W. Segal,, A. Fischer,, D. Kumararatne,, and J. L. Casanova. 1998a. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432 1435.
12. Altare, F.,, E. Jouanguy,, S. Lamhamedi,, R. Doffinger,, A. Fischer,, and J. L. Casanova. 1998b. Mendelian susceptibility to mycobacterial infection in man. Curr. Opin. Immunol. 10: 413 417.
13. Altare, F.,, D. Lammas,, P. Revy,, E. Jouanguy,, R. Doffinger,, S. Lamhamedi,, P. Drysdale,, D. Scheel-Toellner,, J. Girdlestone,, P. Darbyshire,, M. Wadhwa,, H. Dockrell,, M. Salmon,, A. Fischer,, A. Durandy,, J. L. Casanova,, and D. S. Kumararatne. 1998c. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J. Clin. Investig. 102: 2035 2040.
14. Barnwell, J. W.,, M. E. Nichols,, and P. Rubinstein. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 169: 1795 1802.
15. Bellamy, R.,, C. Ruwende,, T. Corrah,, K. P. McAdam,, M. Thursz,, H. C. Whittle,, and A. V. Hill. 1999. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 179: 721 724.
16. Bellamy, R.,, C. Ruwende,, T. Corrah,, K. P. McAdam,, H. C. Whittle,, and A. V. Hill. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338: 640 644.
17. Blackwell, J. M.,, G. F. Black,, C. S. Peacock,, E. N. Miller,, D. Sibthorpe,, D. Gnananandha,, J. J. Shaw,, F. Silveira,, Z. Lins- Lainson,, F. Ramos,, A. Collins,, and M. A. Shaw. 1997. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Philos. Trans. R. Soc. London Ser. B 352: 1331 1345.
18. Blackwell, J. M.,, G. F. Black,, C. Sharples,, S. S. Soo,, C. S. Peacock,, and N. Miller. 1999. Roles of Nramp1, HLA, and a gene(s) in allelic association with IL-4, in determining T helper subset differentiation. Microbes Infect. 1: 95 102.
19. Canonne-Hergaux, F.,, S. Gruenheid,, G. Govoni,, and P. Gros. 1999. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc. Assoc. Am. Physicians 111: 283 289.
20. Casanova, J. L.,, S. Blanche,, J. F. Emile,, E. Jouanguy,, S. Lamhamedi,, F. Altare,, J. L. Stephan,, F. Bernaudin,, P. Bordigoni,, D. Turck,, A. Lachaux,, M. Albertini,, A. Bourrillon,, J. P. Dommergues,, M. A. Pocidalo,, F. Le Deist,, J. L. Gaillard,, C. Griscelli,, and A. Fischer. 1996. Idiopathic disseminated bacillus Calmette- Guerin infection: a French national retrospective study. Pediatrics 98: 774 778.
21. Casanova, J. L.,, E. Jouanguy,, S. Lamhamedi,, S. Blanche,, and A. Fischer. 1995. Immunological conditions of children with BCG disseminated infection. Lancet 346: 581.
22. Casanova, J. L.,, M. Newport,, A. Fischer,, and M. Levin,. 1999. Inherited interferon gamma receptor deficiency, p. 209 221. In H. D. Ochs,, E. Smith,, and J. Puck (ed.), Primary Immunodeficiency Diseases: a Molecular and Genetic Approach. Oxford University Press, New York, N.Y..
23. Cellier, M.,, G. Govoni,, S. Vidal,, T. Kwan,, N. Groulx,, J. Liu,, F. Sanchez,, E. Skamene,, E. Schurr,, and P. Gros. 1994. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J. Exp. Med. 180: 1741 1752.
24. Collins, F. S. 1995. Positional cloning moves from perditional to traditional. Nat. Genet. 9: 347 350.
25. Couissinier-Paris, P.,, and A. J. Dessein. 1995. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 25: 2295 2302.
26. de Jong, R.,, F. Altare,, I. A. Haagen,, D. G. Elferink,, T. Boer,, P. J. van Breda Vriesman,, P. J. Kabel,, J. M. Draaisma,, J. T. van Dissel,, F. P. Kroon,, J. L. Casanova,, and T. H. Ottenhoff. 1998. Severe mycobacterial and Salmonella infections in interleukin- 12 receptor-deficient patients. Science 280: 1435 1438.
27. Dessein, A. J.,, D. Hillaire,, N. E. Elwali,, S. Marquet,, Q. Mohamed- Ali,, A. Mirghani,, S. Henri,, A. A. Abdelhameed,, O. K. Saeed,, M. M. Magzoub,, and L. Abel. 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am. J. Hum. Genet. 65: 709 721.
28. Dib, C.,, S. Faure,, C. Fizames,, D. Samson,, N. Drouot,, A. Vignal,, P. Millasseau,, S. Marc,, J. Hazan,, E. Seboun,, M. Lathrop,, G. Gyapay,, J. Morissette,, and J. Weissenbach. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152 154.
29. Dieye, A.,, C. Rogier,, J. F. Trape,, J. L. Sarthou,, and P. Druilhe. 1997. HLA class I-associated resistance to severe malaria: a parasitological re-assessment. Parasitol. Today 13: 48 49.
30. Doffinger, R.,, E. Jouanguy,, S. Dupuis,, M. C. Fondaneche,, J. L. Stephan,, J. F. Emile,, S. Lamhamedi-Cherradi,, F. Altare,, A. Pallier,, G. Barcenas-Morales,, E. Meinl,, C. Krause,, S. Pestka,, R. D. Schreiber,, F. Novelli,, and J. L. Casanova. 2000. Partial interferon- gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection. J. Infect. Dis. 181: 379 384.
31. Dorman, S. E.,, and S. M. Holland. 1998. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Investig. 101: 2364 2369.
32. Dye, C.,, S. Scheele,, P. Dolin,, V. Pathania,, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677 686.
33. Emile, J. F.,, N. Patey,, F. Altare,, S. Lamhamedi,, E. Jouanguy,, F. Boman,, J. Quillard,, M. Lecomte-Houcke,, O. Verola,, J. F. Mousnier,, F. Dijoud,, S. Blanche,, A. Fischer,, N. Brousse,, and J. L. Casanova. 1997. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J. Pathol. 181: 25 30.
34. Fine, P. E. 1981. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. Int. J. Lepr. Other Mycobact. Dis. 49: 437 454.
35. Foote, S. J.,, R. A. Burt,, T. M. Baldwin,, A. Presente,, A. W. Roberts,, Y. L. Laural,, A. M. Lew,, and V. M. Marshall. 1997. Mouse loci for malaria-induced mortality and the control of parasitaemia. Nat. Genet. 17: 380 381.
36. Fortin, A.,, A. Belouchi,, M. F. Tam,, L. Cardon,, E. Skamene,, M. M. Stevenson,, and P. Gros. 1997. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat. Genet. 17: 382 383.
37. Frucht, D. M.,, and S. M. Holland. 1996. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J. Immunol. 157: 411 416.
38. Garcia, A.,, M. Cot,, J. P. Chippaux,, S. Ranque,, J. Feingold,, F. Demenais,, and L. Abel. 1998a. Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am. J. Trop. Med. Hyg. 58: 480 488.
39. Garcia, A.,, S. Marquet,, B. Bucheton,, D. Hillaire,, M. Cot,, N. Fievet,, A. J. Dessein,, and L. Abel. 1998b. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J. Trop. Med. Hyg. 58: 705 709.
40. Gilbert, S. C.,, M. Plebanski,, S. Gupta,, J. Morris,, M. Cox,, M. Aidoo,, D. Kwiatkowski,, B. M. Greenwood,, H. C. Whittle,, and A. V. Hill. 1998. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279: 1173 1177.
41. Goldfeld, A. E.,, J. C. Delgado,, S. Thim,, M. V. Bozon,, A. M. Uglialoro,, D. Turbay,, C. Cohen,, and E. J. Yunis. 1998. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 279: 226 228.
42. Goldfeld, A. E.,, and E. Y. Tsai. 1996. TNF-alpha and genetic susceptibility to parasitic disease. Exp. Parasitol. 84: 300 303.
43. Govoni, G.,, S. Vidal,, S. Gauthier,, E. Skamene,, D. Malo,, and P. Gros. 1996. The Bcg/ Ity /Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Infect. Immun. 64: 2923 2929.
44. Hill, A. V. 1998. The immunogenetics of human infectious diseases. Annu. Rev. Immunol. 16: 593 617.
45. Hill, A. V.,, C. E. Allsopp,, D. Kwiatkowski,, N. M. Anstey,, P. Twumasi,, P. A. Rowe,, S. Bennett,, D. Brewster,, A. J. Mc- Michael,, and B. M. Greenwood. 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595 600.
46. Hill, A. V.,, J. Elvin,, A. C. Willis,, M. Aidoo,, C. E. Allsopp,, F. M. Gotch,, X. M. Gao,, M. Takiguchi,, B. M. Greenwood,, A. R. Townsend,, A. J. McMichael,, and H. C. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434 439.
47. Holland, S. M.,, S. E. Dorman,, A. Kwon,, I. F. Pitha-Rowe,, D. M. Frucht,, S. M. Gerstberger,, G. J. Noel,, P. Vesterhus,, M. R. Brown,, and T. A. Fleisher. 1998. Abnormal regulation of interferon- gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J. Infect. Dis. 178: 1095 1104.
48. Iwamoto, S.,, T. Omi,, E. Kajii,, and S. Ikemoto. 1995. Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85: 622 626.
49. Jacobson, R. R.,, and J. L. Krahenbuhl. 1999. Leprosy. Lancet 353: 655 660.
50. Jepson, A.,, W. Banya,, F. Sisay-Joof,, M. Hassan-King,, C. Nunes,, S. Bennett,, and H. Whittle. 1997. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infect. Immun. 65: 872 876.
51. Jouanguy, E.,, F. Altare,, S. Lamhamedi,, P. Revy,, J. F. Emile,, M. Newport,, M. Levin,, S. Blanche,, E. Seboun,, A. Fischer,, and J. L. Casanova. 1996. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335: 1956 1961.
52. Jouanguy, E.,, R. Doffinger,, S. Dupuis,, A. Pallier,, F. Altare,, and J. L. Casanova. 1999a. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11: 346 351.
53. Jouanguy, E.,, S. Dupuis,, A. Pallier,, R. Doffinger,, M. C. Fondaneche,, C. Fieschi,, S. Lamhamedi-Cherradi,, F. Altare,, J. F. Emile,, P. Lutz,, P. Bordigoni,, H. Cokugras,, N. Akcakaya,, J. Landman- Parker,, J. Donnadieu,, Y. Camcioglu,, and J. L. Casanova. 2000. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J. Clin. Investig. 105: 1429 1436.
54. Jouanguy, E.,, S. Lamhamedi-Cherradi,, F. Altare,, M. C. Fondaneche,, D. Tuerlinckx,, S. Blanche,, J. F. Emile,, J. L. Gaillard,, R. Schreiber,, M. Levin,, A. Fischer,, C. Hivroz,, and J. L. Casanova. 1997. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J. Clin. Investig. 100: 2658 2664.
55. Jouanguy, E.,, S. Lamhamedi-Cherradi,, D. Lammas,, S. E. Dorman,, M. C. Fondaneche,, S. Dupuis,, R. Doffinger,, F. Altare,, J. Girdlestone,, J. F. Emile,, H. Ducoulombier,, D. Edgar,, J. Clarke,, V. A. Oxelius,, M. Brai,, V. Novelli,, K. Heyne,, A. Fischer,, S. M. Holland,, D. S. Kumararatne,, R. D. Schreiber,, and J. L. Casanova. 1999b. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21: 370 378.
56. Khoury, M. J.,, T. H. Beaty,, and B. H. Cohen. 1993. Fundamentals of genetic epidemiology. Monogr. Epidemiol. Biostat. 19: 1 448.
57. Knight, J. C.,, I. Udalova,, A. V. Hill,, B. M. Greenwood,, N. Peshu,, K. Marsh,, and D. Kwiatkowski. 1999. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22: 145 150.
58. Kruglyak, L. 1999. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat. Genet. 22: 139 144.
59. Lander, E. S.,, and N. J. Schork. 1994. Genetic dissection of complex traits. Science 265: 2037 2048.
60. Levee, G.,, J. Liu,, B. Gicquel,, S. Chanteau,, and E. Schurr. 1994. Genetic control of susceptibility to leprosy in French Polynesia; no evidence for linkage with markers on telomeric human chromosome 2. Int. J. Lepr. Other Mycobact. Dis. 62: 499 511.
61. Levin, M.,, M. J. Newport,, S. D’Souza,, P. Kalabalikis,, I. N. Brown,, H. M. Lenicker,, P. V. Agius,, E. G. Davies,, A. Thrasher,, N. Klein,, and J. M. Blackwell. 1995. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 345: 79 83.
62. Malo, D.,, K. Vogan,, S. Vidal,, J. Hu,, M. Cellier,, E. Schurr,, A. Fuks,, N. Bumstead,, K. Morgan,, and P. Gros. 1994. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23: 51 61.
63. Marquet, S.,, L. Abel,, D. Hillaire,, and A. Dessein. 1999. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur. J. Hum. Genet. 7: 88 97.
64. Marquet, S.,, L. Abel,, D. Hillaire,, H. Dessein,, J. Kalil,, J. Feingold,, J. Weissenbach,, and A. J. Dessein. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14: 181 184.
65. Marsh, D. G.,, J. D. Neely,, D. R. Breazeale,, B. Ghosh,, L. R. Freidhoff,, E. Ehrlich-Kautzky,, C. Schou,, G. Krishnaswamy,, and T. H. Beaty. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264: 1152 1156.
66. McGuire, W.,, A. V. Hill,, C. E. Allsopp,, B. M. Greenwood,, and D. Kwiatkowski. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508 510.
67. McKusick, V. A. 1998. Mendelian Inheritance in Man. Johns Hopkins University Press, Baltimore, Md..
68. McLeod, R.,, E. Buschman,, L. D. Arbuckle,, and E. Skamene. 1995. Immunogenetics in the analysis of resistance to intracellular pathogens. Curr. Opin. Immunol. 7: 539 552.
69. Meyers, D. A.,, D. S. Postma,, C. I. Panhuysen,, J. Xu,, P. J. Amelung,, R. C. Levitt,, and E. R. Bleecker. 1994. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23: 464 470.
70. Miller, L. H. 1994. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc. Natl. Acad. Sci. USA 91: 2415 2419.
71. Miller, L. H.,, S. J. Mason,, D. F. Clyde,, and M. H. McGinniss. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295: 302 304.
72. Misra, N.,, A. Murtaza,, B. Walker,, N. P. Narayan,, R. S. Misra,, V. Ramesh,, S. Singh,, M. J. Colston,, and I. Nath. 1995. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 86: 97 103.
73. Modiano, D.,, V. Petrarca,, B. S. Sirima,, I. Nebie,, D. Diallo,, F. Esposito,, and M. Coluzzi. 1996. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc. Natl. Acad. Sci. USA 93: 13206 13211.
74. Mohamed-Ali, Q.,, N. E. Elwali,, A. A. Abdelhameed,, A. Mergani,, S. Rahoud,, K. E. Elagib,, O. K. Saeed,, L. Abel,, M. M. Magzoub,, and A. J. Dessein. 1999. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J. Infect. Dis. 180: 1298 1306.
75. Morton, N. E. 1955. Sequential tests for the detection of linkage. Am. J. Hum. Genet. 7: 277 318.
76. Muller-Myhsok, B.,, and L. Abel. 1997. Genetic analysis of complex diseases. Science 275: 1328 1329.
77. Muller-Myhsok, B.,, F. F. Stelma,, F. Guisse-Sow,, B. Muntau,, T. Thye,, G. D. Burchard,, B. Gryseels,, and R. D. Horstmann. 1997. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni. Am. J. Hum. Genet. 61: 452 454.
78. Nagel, R. L.,, and E. F. Roth, Jr. 1989. Malaria and red cell genetic defects. Blood 74: 1213 1221.
79. Newport, M. J.,, C. M. Huxley,, S. Huston,, C. M. Hawrylowicz,, B. A. Oostra,, R. Williamson,, and M. Levin. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941 1949.
80. Ott, J. 1999. Analysis of Human Genetic Linkage. Johns Hopkins University Press, Baltimore, Md..
81. Ottenhoff, T. H.,, and R. R. de Vries. 1987. HLA class II immune response and suppression genes in leprosy. Int. J. Lepr. Other Mycobact. Dis. 55: 521 534.
82. Pierre-Audigier, C.,, E. Jouanguy,, S. Lamhamedi,, F. Altare,, J. Rauzier,, V. Vincent,, D. Canioni,, J. F. Emile,, A. Fischer,, S. Blanche,, J. L. Gaillard,, and J. L. Casanova. 1997. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24: 982 984.
83. Postma, D. S.,, E. R. Bleecker,, P. J. Amelung,, K. J. Holroyd,, J. Xu,, C. I. Panhuysen,, D. A. Meyers,, and R. C. Levitt. 1995. Genetic susceptibility to asthma—bronchial hyperresponsiveness coinherited with a major gene for atopy. N. Engl. J. Med. 333: 894 900.
84. Rihet, P.,, L. Abel,, Y. Traore,, T. Traore-Leroux,, C. Aucan,, and F. Fumoux. 1998a. Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso. Genet. Epidemiol. 15: 435 450.
85. Rihet, P.,, Y. Traore,, L. Abel,, C. Aucan,, T. Traore-Leroux,, and F. Fumoux. 1998b. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am. J. Hum. Genet. 63: 498 505.
86. Rioux, J. D.,, V. A. Stone,, M. J. Daly,, M. Cargill,, T. Green,, H. Nguyen,, T. Nutman,, P. A. Zimmerman,, M. A. Tucker,, T. Hudson,, A. M. Goldstein,, E. Lander,, and A. Y. Lin. 1998. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am. J. Hum. Genet. 63: 1086 1094.
87. Rodrigues, V., Jr., L. Abel, K. Piper, and A. J. Dessein. 1996. Segregation analysis indicates a major gene in the control of interleukine-5 production in humans infected with Schistosoma mansoni. Am. J. Hum. Genet. 59: 453 461.
88. Rodrigues, V., Jr., K. Piper, P. Couissinier-Paris, O. Bacelar, H. Dessein, and A. J. Dessein. 1999. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes. Infect. Immun. 67: 4689 4692.
89. Roesler, J.,, B. Kofink,, J. Wendisch,, S. Heyden,, D. Paul,, W. Friedrich,, J. L. Casanova,, W. Leupold,, M. Gahr,, and A. Rosen-Wolff. 1999. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma- receptor (IFNγR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp. Hematol. 27: 1368 1374.
90. Roy, S.,, A. Frodsham,, B. Saha,, S. K. Hazra,, C. G. Mascie-Taylor,, and A. V. Hill. 1999. Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis. 179: 187 191.
91. Ruwende, C.,, S. C. Khoo,, R. W. Snow,, S. N. Yates,, D. Kwiatkowski,, S. Gupta,, P. Warn,, C. E. Allsopp,, S. C. Gilbert,, N. Peschu,, C. I. Newbold,, B. M. Greenwood,, K. Marsh,, and A. V. S. Hill. 1995. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246 249.
92. Sansonetti, P.,, and P. H. Lagrange. 1981. The immunology of leprosy: speculations on the leprosy spectrum. Rev. Infect. Dis. 3: 422 469.
93. Shaw, M. A.,, S. Atkinson,, H. Dockrell,, R. Hussain,, Z. Lins- Lainson,, J. Shaw,, F. Ramos,, F. Silveira,, S. Q. Mehdi,, F. Kaukab,, S. Khaliq,, T. Chiang,, and J. Blackwell. 1993. An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/ Ity /Bcg gene homologue influencing susceptibility to leprosy. Ann. Hum. Genet. 57: 251 271.
94. Shaw, M. A.,, A. Collins,, C. S. Peacock,, E. N. Miller,, G. F. Black,, D. Sibthorpe,, Z. Lins-Lainson,, J. J. Shaw,, F. Ramos,, F. Silveira,, and J. M. Blackwell. 1997. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tubercle Lung Dis. 78: 35 45.
95. Sjoberg, K.,, J. P. Lepers,, L. Raharimalala,, A. Larsson,, O. Olerup,, N. T. Marbiah,, M. Troye-Blomberg,, and P. Perlmann. 1992. Genetic regulation of human anti-malarial antibodies in twins. Proc. Natl. Acad. Sci. USA 89: 2101 2104.
96. Spielman, R. S.,, R. E. McGinnis,, and W. J. Ewens. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52: 506 516.
97. Stead, W. W.,, J. W. Senner,, W. T. Reddick,, and J. P. Lofgren. 1990. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322: 422 427.
98. Tournamille, C.,, Y. Colin,, J. P. Cartron,, and C. Le Van Kim. 1995. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10: 224 228.
99. Udhayakumar, V.,, J. M. Ongecha,, Y. P. Shi,, M. Aidoo,, A. S. Orago,, A. J. Oloo,, W. A. Hawley,, B. L. Nahlen,, S. L. Hoffman,, W. R. Weiss,, and A. A. Lal. 1997. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults. Eur. J. Immunol. 27: 1952 1957.
100. van Eden, W.,, and R. R. P. de Vries. 1984. HLA and leprosy: a reevaluation. Lepr. Rev. 55: 89 104.
101. van Eden, W.,, N. M. Gonzalez,, R. R. de Vries,, J. Convit,, and J. J. van Rood. 1985. HLA-linked control of predisposition to lepromatous leprosy. J. Infect. Dis. 151: 9 14.
102. Vidal, S. M.,, E. Pinner,, P. Lepage,, S. Gauthier,, and P. Gros. 1996. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J. Immunol. 157: 3559 3568.
103. Wakelin, D.,, and J. M. Blackwell. 1988. Genetics of Resistance to Bacterial and Parasitic Infection. Taylor & Francis, London, United Kingdom.
104. Wang, D. G.,, J. B. Fan,, C. J. Siao,, A. Berno,, P. Young,, R. Sapolsky,, G. Ghandour,, N. Perkins,, E. Winchester,, J. Spencer,, L. Kruglyak,, L. Stein,, L. Hsie,, T. Topaloglou,, E. Hubbell,, E. Robinson,, M. Mittmann,, M. S. Morris,, N. Shen,, D. Kilburn,, J. Rioux,, C. Nusbaum,, S. Rozen,, T. J. Hudson,, R. Lipshutz,, M. Chee,, and E. S. Lander. 1998. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280: 1077 1082.
105. Weatherall, D. J. 1987. Common genetic disorders of the red cell and the ‘‘malaria hypothesis.’’ Ann. Trop. Med. Parasitol. 81: 539 548.
106. Wilkinson, R. J.,, M. Llewelyn,, Z. Toossi,, P. Patel,, G. Pasvol,, A. Lalvani,, D. Wright,, M. Latif,, and R. N. Davidson. 2000. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355: 618 621.
107. Wilkinson, R. J.,, P. Patel,, M. Llewelyn,, C. S. Hirsch,, G. Pasvol,, G. Snounou,, R. N. Davidson,, and Z. Toossi. 1999. . J. Exp. Med. 189: 1863 1874.
108. Wilson, A. G.,, J. A. Symons,, T. L. McDowell,, H. O. McDevitt,, and G. W. Duff. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195 3199.
109. World Health Organization. 1997. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin. Exp. Immunol. 109(Suppl. 1): 128.
110. Yamamura, M.,, K. Uyemura,, R. J. Deans,, K. Weinberg,, T. H. Rea,, B. R. Bloom,, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277 279.
111. Zerva, L.,, B. Cizman,, N. K. Mehra,, S. K. Alahari,, R. Murali,, C. M. Zmijewski,, M. Kamoun,, and D. S. Monos. 1996. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J. Exp. Med. 183: 829 836.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error